AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-733 Cr | ₹-1,051 Cr | ₹-108 Cr | ₹-460 Cr | ₹-318 Cr |
What is the latest Cash Flow from Financing Activities ratio of AJANTA PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-733 Cr |
| Mar2024 | ₹-1,051 Cr |
| Mar2023 | ₹-108 Cr |
| Mar2022 | ₹-460 Cr |
| Mar2021 | ₹-318 Cr |
How is Cash Flow from Financing Activities of AJANTA PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-733 Cr | Negative | |
| Mar2024 | ₹-1,051 Cr | Negative | |
| Mar2023 | ₹-108 Cr | Negative | |
| Mar2022 | ₹-460 Cr | Negative | |
| Mar2021 | ₹-318 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹33,937.2 Cr | 0.1% | 1.4% | -5.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 0.1% |
1.4% |
-5.6% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses